Cargando…

Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis

BACKGROUND: It was urgent and necessary to synthesize the evidence for vaccine effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a systematic review and meta-analysis to provide a comprehensive overview of the effectiveness profile of COVID-19 vaccines against VOC. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Baoqi, Gao, Le, Zhou, Qingxin, Yu, Kai, Sun, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126103/ https://www.ncbi.nlm.nih.gov/pubmed/35606843 http://dx.doi.org/10.1186/s12916-022-02397-y

Ejemplares similares

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
por: Bian, Lianlian, et al.
Publicado: (2022)

Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
por: Kumari, Monika, et al.
Publicado: (2023)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
por: Al-Fattah Yahaya, Abdul Aziz, et al.
Publicado: (2023)

A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
por: Wang, Ziyan, et al.
Publicado: (2022)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

SARS-CoV-2 Variants of Concern
por: Choi, Jun Yong, et al.
Publicado: (2021)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot
por: Paetzold, Jörg, et al.
Publicado: (2022)

Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern
por: Su, Shan, et al.
Publicado: (2022)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

SARS -CoV-2 T-cell immunity to variants of concern following vaccination
por: Gallagher, Kathleen M.E., et al.
Publicado: (2021)

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
por: Becker, Matthias, et al.
Publicado: (2021)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

The emerging SARS-CoV-2 variants of concern
por: Sanyaolu, Adekunle, et al.
Publicado: (2021)

The origin of SARS-CoV-2 variants of concern
por: Burki, Talha
Publicado: (2022)

Dermal Delivery of a SARS-CoV-2 Subunit Vaccine Induces Immunogenicity against Variants of Concern
por: McMillan, Christopher L. D., et al.
Publicado: (2022)

Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2
por: Mahmoud, Sally, et al.
Publicado: (2022)

Multivalent designed proteins protect against SARS-CoV-2 variants of concern
por: Hunt, Andrew C., et al.
Publicado: (2021)

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
por: Schmitz, Katharina S., et al.
Publicado: (2022)

Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
por: Khaleeq, Sara, et al.
Publicado: (2023)

Author Correction: Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

A highly potent antibody effective against SARS-CoV-2 variants of concern
por: Fenwick, Craig, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
por: Shao, Weihao, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern: the knowns and unknowns
por: Lessells, Richard J.
Publicado: (2021)

The Immune Response to SARS-CoV-2 and Variants of Concern
por: Torbati, Elham, et al.
Publicado: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
por: La Porta, Caterina A. M., et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

The Emerging Concern and Interest SARS-CoV-2 Variants
por: Janik, Edyta, et al.
Publicado: (2021)

The Spike of Concern—The Novel Variants of SARS-CoV-2
por: Winger, Anna, et al.
Publicado: (2021)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

On the evolution of SARS-CoV-2 and the emergence of variants of concern
por: Magiorkinis, Gkikas
Publicado: (2023)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern
por: Wang, Haomeng, et al.
Publicado: (2022)

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
por: González-Domínguez, Irene, et al.
Publicado: (2022)

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
por: Shi, Juan, et al.
Publicado: (2022)

Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
por: Ruhl, Louisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dkiqr9ue5nsqcng9tusfued0qg